Whitehawk Therapeutics posts corporate deck highlighting ADC platform and Phase 1 pipeline progressPUBT·Aug 6 at 07:10 AMWHWK+0.62%
Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation | AKTX Stock NewsStockTitan·Aug 3 at 11:50 PMAKTX-0.99%WHWK+0.62%
Akari Therapeutics enters strategic ADC payload research collaboration with Whitehawk TherapeuticsPUBT·Jul 22 at 07:40 AMWHWK+0.62%AKTX-0.99%
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology OpportunityGlobeNewswire·Jul 22 at 07:40 AMAKTX-0.99%WHWK+0.62%
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics | AKTX Stock NewsStockTitan·Jul 20 at 10:05 PMAKTX-0.99%WHWK+0.62%
